2-(furan-2-yl)-7-methoxy-4H-chromen-4-one | 30245-24-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 2-(furan-2-yl)-7-methoxy-4H-chromen-4-one
• 英文别名: 7-Methoxy-2-furyl-(2)-chromon；2-furan-2-yl-7-methoxy-chromen-4-one；2-[2]furyl-7-methoxy-chromen-4-one；2-[2]Furyl-7-methoxy-chromen-4-on；2-(Furan-2-yl)-7-methoxychromen-4-one
• CAS: 30245-24-0
• 化学式: C₁₄H₁₀O₄
• 分子量: 242.231
• InChiKey: KQHQZBSBDPCJAM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  48.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  间苯二酚 在 盐酸 、 potassium carbonate 、 sodium hydroxide 、 zinc(II) chloride 作用下， 以 乙醚 、 乙醇 、 水 为溶剂， 生成 2-(furan-2-yl)-7-methoxy-4H-chromen-4-one
  参考文献：
  名称：

  Inhibitory effect of flavonoids on human glutaminyl cyclase

  摘要：

  Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents. However, the study of QC inhibitors are still less. Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivatives were synthesized as a new class of human QC (hQC) inhibitors. The efficacy investigation of these compounds was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated. Molecular docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2016.03.064

文献信息

• Marini-Bettolo, Gazzetta Chimica Italiana, 1941, vol. 71, p. 635,640
  作者：Marini-Bettolo

  DOI：——

  日期：——
• Inhibitory effect of flavonoids on human glutaminyl cyclase
  作者：Manman Li、Yao Dong、Xi Yu、Yongdong Zou、Yizhi Zheng、Xianzhang Bu、Junmin Quan、Zhendan He、Haiqiang Wu

  DOI：10.1016/j.bmc.2016.03.064

  日期：2016.5

  Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents. However, the study of QC inhibitors are still less. Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivatives were synthesized as a new class of human QC (hQC) inhibitors. The efficacy investigation of these compounds was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated. Molecular docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC. (C) 2016 Elsevier Ltd. All rights reserved.